Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFDM Group Regulatory News (FDM)

Share Price Information for FDM Group (FDM)

Share Price is delayed by 15 minutes
Get Live Data
100.20    -5.60 (-5.29%)
Bid:
101.40
Ask:
105.60
Spread: 4.20 (4.142%)
Market Cap: £109.56m
FDM Live PriceLast checked at - London Stock Exchange

Intraday FDM Group Share Chart

Ford to Restate Results

23 Oct 2006 14:19

Ford Motor Co23 October 2006 Contact: Media: Equity Investment Fixed Income Shareholder Inquiries: Becky Sanch Community: Investment Community: 1.800.555.5259 or 1.313.594.4410 Raj Modi Rob Moeller 1.313.845.8540 bsanch@ford.com 1.313.323.8221 1.313.621.0881 stockinf@ford.com fordir@ford.com fixedinc@ford.com Editor's note: The following is one of two related press releases Ford MotorCompany is issuing today. Please also refer to the release entitled: "FORDREPORTS PRELIMINARY THIRD QUARTER 2006 FINANCIAL RESULTS." FORD TO RESTATE RESULTS SINCE 2001 FOR ACCOUNTING UNDER SFAS 133 DEARBORN, Mich., Oct. 23, 2006 - Ford Motor Company (NYSE: F) today announced itplans to restate previous financial results from 2001 through the second quarterof 2006 to correct the accounting for certain derivative transactions under theStatement of Financial Accounting Standards (SFAS) 133, Accounting for Derivative Instruments and Hedging Activities. The correction to the accounting does not affect the economics of the derivativetransactions, nor have any impact on the company's cash. However, therestatements are expected to affect the preliminary financial results Fordannounced today for its 2006 third quarter. The company expects to finalizerestatement amounts for the current period and all previous periods by the timeof the filing of its Quarterly Report on Form 10-Q for the quarter ended Sept.30, 2006. (For full details regarding Ford's preliminary results for the 2006third quarter, please see press release entitled, "FORD REPORTS PRELIMINARYTHIRD QUARTER 2006 FINANCIAL RESULTS.") Ford discovered that since 2001, certain interest rate swaps Ford Motor CreditCompany had entered into to hedge the interest rate risk inherent in certainlong-term fixed rate debt were accounted for incorrectly under SFAS 133 becausethey did not satisfy the standard's technical accounting rules to qualify forexemption from the more strict effectiveness testing requirements. Ford MotorCredit Company uses transactions involving derivatives, including swaps,forwards and options, to reduce economic risk and volatility in a disciplinedand defensive manner. PricewaterhouseCoopers LLP, the company's independentregistered public accounting firm, audited Ford's 2001 through 2005 financialstatements, which included a review of these swaps. "This is a very complicated accounting standard, and interpretation of itsproper application has continued to evolve," said Executive Vice President andChief Financial Officer Don Leclair. "Our overall hedging strategy is sound. Wewill correct our accounting for these types of derivative instruments. We remaincommitted to strong internal controls and reporting transparency." Ford Motor Credit Company's interest rate swaps were entered into as part of theunit's asset-liability management strategy. The swaps economically hedge theinterest rate risk associated with long-term debt issuances. Although the finalrestatement amounts have not yet been determined, we estimate based on theinformation to date that Ford and Ford Motor Credit Company's results in 2002will improve materially. Other periods are still under study. About Ford Motor Company Ford Motor Company, a global automotive industry leader based in Dearborn,Mich., manufactures and distributes automobiles in 200 markets across sixcontinents. With about 300,000 employees and 108 plants worldwide, the company'score and affiliated automotive brands include Aston Martin, Ford, Jaguar, LandRover, Lincoln, Mazda, Mercury and Volvo. Its automotive-related servicesinclude Ford Motor Credit Company. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jun 20268:24 amRNSDisclosure of PSP Performance Condition Targets
3rd Jun 202611:01 amRNSAdmission to Trading
2nd Jun 20262:23 pmRNSDirector Shareholding & Block Listing Application
1st Jun 20267:00 amRNSTotal Voting Rights
21st May 20264:39 pmRNSResult of AGM
21st May 20267:00 amRNSAGM Statement
27th Apr 20263:51 pmRNSNotification of Transactions of Directors & PDMRs
21st Apr 20262:18 pmRNSDirector / PCA Shareholding
20th Apr 20267:00 amRNSDirector / PCA Shareholding
10th Apr 20264:34 pmRNS2026 Notice of Annual General Meeting
20th Mar 20265:18 pmRNSHolding(s) in Company
18th Mar 20267:00 amRNSPreliminary Results
2nd Mar 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTotal Voting Rights
28th Jan 20267:00 amRNSTrading Statement
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
1st Dec 20259:17 amRNSTotal Voting Rights
13th Nov 202512:35 pmRNSHolding(s) in Company
11th Nov 20257:00 amRNSTrading Statement
6th Nov 20254:05 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTotal Voting Rights
17th Oct 20251:03 pmRNSDirector/PDMR Shareholding
4th Sep 20254:31 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSHolding(s) in Company
8th Aug 202510:55 amRNSDirector/PDMR Shareholding
5th Aug 202510:03 amRNSHolding(s) in Company
1st Aug 20258:50 amRNSTotal Voting Rights
31st Jul 20255:27 pmRNSPDMR Shareholding
31st Jul 20253:45 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSHalf-year Report
15th Jul 20255:07 pmRNSHolding(s) in Company
7th Jul 20259:48 amRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirectorate Change
6th Jun 20257:00 amRNSDirector/PDMR Shareholding
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
23rd May 20255:07 pmRNSDirector/PCA Shareholding
20th May 20255:28 pmRNSResult of AGM
20th May 20257:00 amRNSAnnual General Meeting Statement
9th May 202511:10 amRNSDirector/PDMR Shareholding
8th May 20252:55 pmRNSDirector/PDMR Shareholding
1st May 20251:17 pmRNSDirector/PDMR Shareholding
23rd Apr 20259:51 amRNSDirector Shareholding
9th Apr 20254:32 pmRNSDirector/PDMR Shareholding
8th Apr 20255:42 pmRNSNotice of Annual General Meeting
1st Apr 20257:00 amRNSTotal Voting Rights
20th Mar 20254:31 pmRNSDirector / PCR Shareholding
19th Mar 20257:00 amRNSDirectorate Change
19th Mar 20257:00 amRNSPreliminary Announcement of Results FY2024
14th Mar 20254:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.